The Annual Biomarkers for Alzheimer’s Disease Summit is running from August 25-26. The industry’s only digital forum focused on sharing innovations in new novel biomarkers and clinically validated biomarkers for the earlier detection and diagnosis of Alzheimer’s disease, an area of intense unmet medical need. Here’s a look at some of the top stories from day one. […]

On this week’s Tech Nation, Moira speaks with ROBERT SIEGEL, Venture Investor and Stanford University Lecturer, and the Author of “The Brains and Brawn Company … How Leading Organizations blend the best of Digital and Physical.” Then, intervening with “cytokine storms”. JIM JOYCE, the CEO of San Diego’s Sigyn Therapeutics talks about their progress to […]

Athersys was started about 25 years ago and is currently developing MultiStem®, a proprietary stem cell product for the treatment of diseases and conditions in the neurological, inflammatory, and immune areas. The company has a clinical trial underway in each of those areas and is conducting studies in the U.S. and internationally. “Our MultiStem product […]